Last reviewed · How we verify
NCT06564350
Digitalization of Measuring Physical Performance
trial testing IMU (Inertial Measurement Unit) sensors in Physical Performance in 10 participants. Completed in 11 August 2023.
4 August 2023
Quick facts
| Lead sponsor | Yale University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 27 July 2023 |
| Primary completion | 4 August 2023 |
| Estimated completion | 11 August 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- IMU (Inertial Measurement Unit) sensors
Conditions studied
- Physical Performance — all drugs for Physical Performance →
Sponsor
Yale University
Who can join
18 and older, any sex, with Physical Performance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigators will test the validity and reproducibility of the measurement of motor performance using wearables and the correlation of this measurement with function and mobility.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06564350
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Physical Performance
Currently open trials in the same condition.
- NCT07272876 — Kinesiophobia and Physical Function in Elderly With Musculoskeletal Pain · active not recruiting
- NCT07347522 — Body Composition and Lifestyle Factors in ROTC · recruiting
- NCT07378007 — Characteristics of Performance in Collegiate Cheerleaders and Dancers · recruiting
- NCT07107984 — Assessment of Physical Performance in Children · active not recruiting
- NCT06925880 — Effect of Micronized Creatine Monohydrate on Muscle Mass, Strength and Performance in Older Adults Submitted to Total Kn · NA · recruiting
Other Yale University trials
Trials by the same sponsor.
- NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
- NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
- NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
- NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
- NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06564350 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yale University
- Last refreshed: 21 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06564350.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing